NEWRON PHARMACEUT. EO-20 (NP5) — Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

NEWRON PHARMACEUT. EO-20 (NP5) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of €32.30 Million represents 1% of operating cash flow (€32.35 Million). See NEWRON PHARMACEUT. EO-20 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

€32.30 Million

EUR

Operating Cash Flow

€32.35 Million

EUR

Capital Expenditures

€48.00K

EUR

NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for NEWRON PHARMACEUT. EO-20 across 1 annual periods. Explore NEWRON PHARMACEUT. EO-20 debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for NEWRON PHARMACEUT. EO-20 (2025–2025)

Year-by-year Free Cash Flow Generation Index for NEWRON PHARMACEUT. EO-20. For the full company profile including market capitalisation, see NP5 market cap overview.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2025	1.00x	€32.30 Million	€32.35 Million	€48.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).